Editorial

Abstract

I am very pleased to announce that the editorial team for the Journal of Pharmaceutical Sciences (JPharmSci®) has decided to dedicate a future issue of the journal to Professors John F. Carpenter and Theodore W. Randolph and to the areas of science that they have loved and fostered throughout their professional careers. Professors Carpenter and Randolph are both distinguished faculty members at the University of Colorado. Professor Carpenter is a professor in the Skaggs School of Pharmacy and Pharmaceutical Sciences in Denver and Professor Randolph is the Kenneth L. and Genevieve G. Gillespie Professor in the College of Engineering and Applied Science in Boulder. The honor of a dedicated issue of JPharmSci® is being bestowed on Professors Carpenter and Randolph because of the tremendous impact that they have had and continue to have on research in the area of pharmaceutical biotechnology, their longstanding commitment to the training and mentoring of the next generation of young scientists in this area, and their dedication to professional service in the pharmaceutical sciences and biological engineering. Professors Carpenter and Randolph are considered by their peers to be “TRUE GIANTS” in the area of pharmaceutical biotechnology. Their specific contributions to pharmaceutical biotechnology will be summarized in a Lead Commentary written by the guest editors and published in the John F. Carpenter and Theodore W. Randolph Dedicated Issue of JPharmSci®. This dedicated issue will also include General Commentaries, Global Health Commentaries, Clinical Trials and Translational Medicine Commentaries, Special Topic Commentaries, Perspectives, Minireviews, Reviews, Rapid Communications, Research Articles, Notes, and Lessons Learned that highlight Professor Carpenter’s and Randolph’s major research interests, which include the following:•Liquid and lyophilized protein formulation development.•Vaccine formulation development.•Thermodynamic (thermal, pressure, protein-solute equilibria) and kinetic mechanisms of protein chemical and physical stability in the liquid and dried state.•Aggregation pathways for protein therapeutics (colloidal and conformational stability).•Protein degradation pathways in manufacturing and drug delivery devices, and during handling in the clinical setting.•Amyloid fibril pathways involved in human diseases.•Immunogenicity of protein therapeutics. I am very pleased to announce that the following eminent scientists have agreed to be the guest editors for this dedicated issue: Professor Eva Chi (University of New Mexico); Professor Wim Jiskoot (Leiden University); Dr. Brent Kendrick (Elion Labs); Dr. Bruce A. Kerwin (Just Biotherapeutics, Inc.); Dr. Linda Narhi (Consultant, Camarillo, CA); Christopher J. Roberts (University of Delaware); Professor Daniel K. Schwartz (University of Colorado Boulder); Professor Susumu Uchiyama (Osaka University); and Professor Gerhard Winter (University of Munich [LMU]). These guest editors would welcome proposals for original scientific articles (Rapid Communications, Research Articles, Notes, Lessons Learned), Commentaries, Perspectives, Minireviews, and Reviews in those research areas of pharmaceutical biotechnology that Professor Carpenter and Randolph have contributed to throughout their professional careers. In addition, the guest editors would also welcome the perspectives of pharmaceutical scientists, in the form of Commentaries, about the significance of Professor Carpenter’s and Randolph’s published research findings on their personal experiences as scientists working in pharmaceutical and biotechnology companies, academia, and government. If you are interested in contributing to this dedicated issue, and thus honoring Professors Carpenter and Randolph, please contact Drs. Eva Chi evachia@unm.edu and/or Brent Kendrick bkendrick@elionlabs.com, who will be serving as the lead guest editors for this dedicated issue. Please be advised that articles for possible inclusion in this dedicated issue will need to be submitted on or before August 16, 2019. The John F. Carpenter and Theodore W. Randolph Dedicated Issue will be published as the January 2020 issue of JPharmSci® on the journal’s website <http://www.jpharmsci.org> where it will be featured under Dedicated Issues of JPharmSci® <https://www.jpharmsci.org/giants-of-pharmaceutical-sciences>. Finally, I am very pleased to inform the readers of JPharmSci® that the content of the John F. Carpenter and Theodore W. Randolph Dedicated Issue of JPharmSci® will be “freely available” to all visitors of the journal’s website.